Genes Affecting β-Cell Function in Type 1 Diabetes

Current Diabetes Reports

Volumn 15, Issue 11, 2015, Pages

  Fløyel, Tina ^a   Kaur, Simranjeet ^a   Pociot, Flemming ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Candidate genes; CTSH; GWAS; Noncoding RNA; Pancreatic islets; T1D

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; UNTRANSLATED RNA; INSULIN;

BACH2 GENE; CLEC16A GENE; CTSH GENE; EPIGENETICS; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLIS3 GENE; HUMAN; IFIH1 GENE; IMMUNE RESPONSE; IMMUNOMODULATION; INS GENE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PTPN2 GENE; REVIEW; SIGNAL TRANSDUCTION; TYK2 GENE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN; INSULIN-SECRETING CELLS; RNA, UNTRANSLATED;

EID: 84942314393     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-015-0655-9     Document Type: Review

References (98)

1. Willcox A, Richardson SJ, Bone AJ, et al. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009;155:173–81.
2. Coppieters KT, Dotta F, Amirian N, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med. 2012;209:51–60.
3. Nerup J, Mandrup-Poulsen T, Helqvist S, et al. On the pathogenesis of IDDM. Diabetologia. 1994;37 Suppl 2:S82–9.
4. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5:219–26.
5. Keenan HA, Sun JK, Levine J, et al. Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes. 2010;59:2846–53.
6. Liu EH, Digon III BJ, Hirshberg B, et al. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft. Diabetologia. 2009;52:1369–80.
7. Gianani R, Campbell-Thompson M, Sarkar SA, et al. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia. 2010;53:690–8.
8. Krogvold L, Skog O, Sundström G, et al.: Function of isolated pancreatic islets from patients at onset of type 1 diabetes; Insulin secretion can be restored after some days in a non-diabetogenic environment in vitro. Results from the DiViD study. Diabetes. 2015. This study shows that restoration of specific function of the isolated islets removed from patients at onset of type 1 diabetes can be obtained afterin vitroculture.
9. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev. 2011;91:79–118.
10. Saisho Y, Butler AE, Manesso E, et al. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36:111–7. This autopsy study of a non-diabetic population suggests that the beta-cell mass may vary a log-fold between individuals.
11. Cooper JD, Smyth DJ, Smiles AM, et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet. 2008;40:1399–401.
12. Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41:703–7.
13. Bradfield JP, Qu HQ, Wang K, et al. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet. 2011;7, e1002293.
14. Onengut-Gumuscu S, Chen WM, Burren O, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47:381–6. The ImmunoChip study of type 1 diabetes susceptibility loci confirms results from previous genome-wide association studies and identifies novel loci and risk variants.
15. Groop L, Pociot F. Genetics of diabetes--are we missing the genes or the disease? Mol Cell Endocrinol. 2014;382:726–39.
16. Wray NR, Yang J, Goddard ME, et al. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet. 2010;6, e1000864.
17. Clayton DG. Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet. 2009;5, e1000540.
18. Manolio TA. Bringing genome-wide association findings into clinical use. Nat Rev Genet. 2013;14:549–58.
19. Pociot F, Akolkar B, Concannon P, et al. Genetics of type 1 diabetes: what’s next? Diabetes. 2010;59:1561–71.
20. Brorsson CA, Onengut S, Chen W-M, et al.: Novel association between immune-mediated susceptibility loci and persistent autoantibody positivity in type 1 diabetes. Diabetes. 2015. The most comprehensive study to demonstrate the genetic association to autoimmunity antibody positivity in type 1 diabetes.
21. Brorsson CA, Pociot F, T1DGC. Shared genetic basis for type 1 diabetes, islet autoantibodies and autoantibodies associated with other immune-mediated diseases in type 1 diabetes families. Diabetes Care. 2015;In Press.
22. Bergholdt R, Brorsson C, Palleja A, et al. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes. 2012;61:954–62. This study provides evidence that many of the genes in the type 1 diabetes susceptibility loci interact in functional networks and that the majority of these genes are expressed in human islets. Furthermore, this study highlights the advantage of integrating several types of data to understand complex diseases including type 1 diabetes.
23. Eizirik DL, Sammeth M, Bouckenooghe T, et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 2012;8, e1002552. This study provides the most comprehensive transcriptome analysis of human islets under control conditions and following exposure to pro-inflammatory cytokines. It demonstrates that many of the candidate genes for type 1 diabetes are expressed in human islets.
24. Storling J, Brorsson CA. Candidate genes expressed in human islets and their role in the pathogenesis of type 1 diabetes. Curr Diab Rep. 2013;13:633–41.
25. Colli ML, Moore F, Gurzov EN, et al. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet. 2010;19:135–46.
26. Lincez PJ, Shanina I, Horwitz MS. Reduced expression of the MDA5 gene IFIH1 prevents autoimmune diabetes. Diabetes. 2015;64:2184–93. This work identifies MDA5 as an important target for preventative and therapeutic strategies to halt T1D. By reducing MDA5 gene expression in NOD mice a unique IFN-I signature that led to expansion of regulatory T cells at the site of autoimmunity and protection from T1D was identified.
27. Moore F, Colli ML, Cnop M, et al. PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis. Diabetes. 2009;58:1283–91.
28. Nogueira TC, Paula FM, Villate O, et al. GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim. PLoS Genet. 2013;9, e1003532. This study demonstrates that the type 1 and type 2 diabetes candidate geneGLIS3has important functions in beta cells and besides its role in insulin transcription also regulates beta cell apoptosis by modulating alternative splicing of the pro-apoptotic protein Bim.
29. Santin I, Moore F, Colli ML, et al. PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic beta-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes. 2011;60:3279–88.
30. Floyel T, Brorsson C, Nielsen LB, et al. CTSH regulates beta-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc Natl Acad Sci U S A. 2014;111:10305–10. This study demonstrates that the type 1 diabetes candidate geneCTSHhas important functions in beta cells, and that type 1 diabetes risk SNPs affectCTSHexpression and beta cell function in type 1 diabetes patients.
31. Marroqui L, Santin I, Dos Santos RS, et al. BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic beta-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2. Diabetes. 2014;63:2516–27.
32. Soleimanpour SA, Gupta A, Bakay M, et al. The diabetes susceptibility gene Clec16a regulates mitophagy. Cell. 2014;157:1577–90. The study describes an important role of the type 1 diabetes candidate geneCLEC16Ain beta cell function and indicates that dysregulated autophagy/mitophagy could be implicated in beta cell dysfunction and development of type 1 diabetes.
33. Izumi K, Mine K, Inoue Y, et al.: Reduced Tyk2 gene expression in beta-cells due to natural mutation determines susceptibility to virus-induced diabetes. Nat Commun. 2015;6
34. Ziegler AG, Hillebrand B, Rabl W, et al. On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia. 1993;36:402–8.
35. Achenbach P, Koczwara K, Knopff A, et al. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest. 2004;114:589–97.
36. Bennett ST, Lucassen AM, Gough SC, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 1995;9:284–92.
37. Liu M, Sun J, Cui J, et al. INS-gene mutations: from genetics and beta cell biology to clinical disease. Mol Asp Med. 2015;42:3–18.
38. Nejentsev S, Walker N, Riches D, et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 2009;324:387–9.
39. Downes K, Pekalski M, Angus KL, et al. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS One. 2010;5, e12646.
40. Skog O, Korsgren O, Frisk G. Modulation of innate immunity in human pancreatic islets infected with enterovirus in vitro. J Med Virol. 2011;83:658–64.
41. Santin I, Eizirik DL. Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and beta-cell apoptosis. Diabetes Obes Metab. 2013;15 Suppl 3:71–81.
42. Cho YS, Chen C-H, Hu C, et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet. 2012;44:67–72.
43. Senee V, Chelala C, Duchatelet S, et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet. 2006;38:682–7.
44. Kang HS, Kim Y-S, ZeRuth G, et al. Transcription factor Glis3, a novel critical player in the regulation of pancreatic β-cell development and insulin gene expression. Mol Cell Biol. 2009;29:6366–79.
45. Yang YS, Chang BHJ, Chan L. Sustained expression of the transcription factor GLIS3 is required for normal beta cell function in adults. Embo Mol Med. 2013;5:92–104.
46. Yang Y, Chang BH-J, Samson SL, et al. The Krüppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription. Nucleic Acids Res. 2009;37:2529–38.
47. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105–16.
48. Barker A, Sharp SJ, Timpson NJ, et al. Association of genetic loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children. Diabetes. 2011;60:1805–12.
49. Wallace C, Smyth DJ, Maisuria-Armer M, et al. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet. 2010;42:68–71.
50. Marroqui L, Santos RSD, Floyel T, et al.: TYK2, a candidate risk gene for type 1 diabetes, modulates apoptosis and the innate immune response in human pancreatic β-cells. Diabetes. 2015.
51. Zhong H, Yang X, Kaplan LM, et al. Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet. 2010;86:581–91.
52. Cho DY, Kim YA, Przytycka TM. Chapter 5: network biology approach to complex diseases. PLoS Comput Biol. 2012;8, e1002820.
53. Gustafsson M, Nestor C, Zhang H, et al. Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Med. 2014;6:82.
54. Mitra K, Carvunis AR, Ramesh SK, et al. Integrative approaches for finding modular structure in biological networks. Nat Rev Genet. 2013;14:719–32.
55. Berchtold LA, Storling ZM, Ortis F, et al. Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis. Proc Natl Acad Sci U S A. 2011;108:E681–8.
56. Lopes M, Kutlu B, Miani M, et al. Temporal profiling of cytokine-induced genes in pancreatic beta-cells by meta-analysis and network inference. Genomics. 2014;103:264–75.
57. Bergholdt R, Storling ZM, Lage K, et al. Integrative analysis for finding genes and networks involved in diabetes and other complex diseases. Genome Biol. 2007;8:R253.
58. Evangelou M, Smyth DJ, Fortune MD, et al. A method for gene-based pathway analysis using genomewide association study summary statistics reveals nine new type 1 diabetes associations. Genet Epidemiol. 2014;38:661–70.
59. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106:9362–7.
60. Eliasson L, Esguerra JL. Role of non-coding RNAs in pancreatic beta-cell development and physiology. Acta Physiol (Oxf). 2014;211:273–84.
61. Plaisance V, Waeber G, Regazzi R, et al. Role of microRNAs in islet beta-cell compensation and failure during diabetes. J Diabetes Res. 2014;2014:618652.
62. Guay C, Jacovetti C, Nesca V, et al. Emerging roles of non-coding RNAs in pancreatic beta-cell function and dysfunction. Diabetes Obes Metab. 2012;14 Suppl 3:12–21.
63. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.
64. Kalis M, Bolmeson C, Esguerra JLS, et al. Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One. 2011;6, e29166.
65. Melkman-Zehavi T, Oren R, Kredo-Russo S, et al. miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors. EMBO J. 2011;30:835–45.
66. Özcan S. Minireview: microRNA function in pancreatic β cells. Mol Endocrinol. 2014;28:1922–33.
67. Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 2013;14:475–88.
68. de Jong VM, Zaldumbide A, van der Slik AR, et al. Post-transcriptional control of candidate risk genes for type 1 diabetes by rare genetic variants. Genes Immun. 2013;14:58–61.
69. Gong W, Xiao D, Ming G, et al. Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites. J Diabetes. 2014;6:279–89.
70. Guay C, Menoud V, Rome S, et al. Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells. Cell Commun Signal. 2015;13:17.
71. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904–14.
72. Knoll M, Lodish HF, Sun L. Long non-coding RNAs as regulators of the endocrine system. Nat Rev Endocrinol. 2015;11:151–60.
73. Morán I, Akerman İ, Van de Bunt M, et al. Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 2012;16:435–48. A comprehensive strand-specific transcriptome map of human pancreatic islets and β-cells. The study uncovers >1100 intergenic and antisense islet-cell lncRNA genes, and show that islet lncRNAs are dynamically regulated and important for β-cell differentiation and maturation.
74. Li B, Bi C, Lang N, et al. RNA-seq methods for identifying differentially expressed gene in human pancreatic islet cells treated with pro-inflammatory cytokines. Mol Biol Rep. 2014;41:1917–25.
75. Benner C, van der Meulen T, Caceres E, et al. The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics. 2014;15:620. A comprehensive mouse alpha and beta cell transcriptome study, which can be a valuable resource to improve the translatability of rodent studies.
76. Mirza AH, Kaur S, Brorsson CA, et al. Effects of GWAS-associated genetic variants on lncRNAs within IBD and T1D candidate loci. PLoS One. 2014;9:e105723. Maps lincRNAs to genomic regions demonstrating GWAS significant association to type 1 diabetes and shows that more than fifty per cent of the genes in these regions are non-protein coding.
77. Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915–27.
78. Nica AC, Ongen H, Irminger JC, et al. Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res. 2013;23:1554–62. Interesting transc11riptome analysis of isolated human islet as well as beta-cells and non-beta cells making it possible to identify beta-cell specific genes.
79. Spitale RC, Flynn RA, Zhang QC, et al. Structural imprints in vivo decode RNA regulatory mechanisms. Nature. 2015;519:486–90.
80. Sandovici I, Hammerle C, Ozanne S, et al. Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes. Cell Mol Life Sci. 2013;70:1575–95.
81. Raciti G, Longo M, Parrillo L, et al.: Understanding type 2 diabetes: from genetics to epigenetics. Acta Diabetol. 2015:1–7.
82. Gilbert ER, Liu D. Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics. 2012;7:841–52.
83. Olsson AH, Volkov P, Bacos K, et al. Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets. PLoS Genet. 2014;10, e1004735. The study identifies a large number of mQTLs in a large set of human islets.
84. Ling C, Poulsen P, Simonsson S, et al. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest. 2007;117:3427–35.
85. Lewis EC, Blaabjerg L, Storling J, et al. The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet beta cells in vivo and in vitro. Mol Med. 2011;17:369–77.
86. Chou Danny H-C, Holson Edward B, Wagner Florence F, et al. Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis. Chem Biol. 2012;19:669–73.
87. De Santis M, Selmi C. The therapeutic potential of epigenetics in autoimmune diseases. Clin Rev Allergy Immunol. 2012;42:92–101.
88. Scharfmann R, Rachdi L, Ravassard P. Concise review: in search of unlimited sources of functional human pancreatic beta cells. Stem Cells Transl Med. 2013;2:61–7.
89. Roep BO, Atkinson M, von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol. 2004;4:989–97.
90. Brissova M, Fowler MJ, Nicholson WE, et al. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem. 2005;53:1087–97.
91. Cabrera O, Berman DM, Kenyon NS, et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A. 2006;103:2334–9.
92. In’t Veld P. Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol. 2014;36:569–79.
93. Reed JC, Herold KC. Thinking bedside at the bench: the NOD mouse model of T1DM. Nat Rev Endocrinol. 2015;11:308–14.
94. Necsulea A, Kaessmann H. Evolutionary dynamics of coding and non-coding transcriptomes. Nat Rev Genet. 2014;15:734–48.
95. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013;110:3507–12.
96. Yue F, Cheng Y, Breschi A, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 2014;515:355–64. A comparison of the transcriptional and cellular regulatory elements in the mouse genome with the human genome. The study demonstrates substantial conservation in functional sequences, but also finds a large degree of divergence of other sequences involved in transcriptional regulation, chromatin state and higher order chromatin organization.
97. Xie C, Yuan J, Li H, et al. NONCODEv4: exploring the world of long non-coding RNA genes. Nucleic Acids Res. 2014;42:D98–103.
98. Sabarinathan R, Tafer H, Seemann SE, et al. RNAsnp: efficient detection of local RNA secondary structure changes induced by SNPs. Hum Mutat. 2013;34:546–56.